Observational studyEye (London, England)2026
Epidemiology and risk factors for corneal blindness in China: a multicentre retrospective study of 15,937 inpatients.
Observational study in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exosomes in corneal diseases: advances in diagnosis and therapy.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo describe the demographic and clinical characteristics of inpatients with corneal blindness in China and identify independent risk factors.
methodsThis multicentre, retrospective, observational study was conducted by 16 clinical centres in 15 provincial-level administrative regions across China. Inpatients discharged with a primary diagnosis of corneal disease between January 1, 2019, and December 31, 2021, were included. The demographic and clinical characteristics of patients with corneal blindness were evaluated, and risk factors were identified via multivariate regression analysis. Regional variations in the corneal blindness and keratoplasty rates were also assessed.
resultsA total of 15,937 patients with corneal diseases were analysed; 9272 of these patients (58.18%) had corneal blindness. Most patients were male (6614 [71.33%]), with a median age of 55 years (IQR 45-66). The most common types of corneal blindness were keratitis (5141 [55.45%]) and corneal injury (3153 [34.01%]). Multivariate regression analysis revealed that male sex (aOR 1.171, 95% CI 1.081-1.268), older age (aOR 1.021, 95% CI 1.019-1.024), rural residence (aOR 1.348, 95% CI 1.254-1.448), lack of medical insurance (aOR 1.215, 95% CI 1.123-1.314), living in the western region (aOR 1.247, 95% CI 1.152-1.350) and having coexisting glaucoma (aOR 2.288, 95% CI 1.890-2.768) were risk factors for corneal blindness. The western region had the highest percentage of corneal blindness cases (p < 0.001, 61.23%) but the lowest percentage of keratoplasty cases (p < 0.001, 24.68%).
conclusionsThe study on identifying risk factors for corneal blindness provides evidence for optimising clinical decision-making and may contribute to reducing the incidence of corneal blindness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.